These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

760 related articles for article (PubMed ID: 29358871)

  • 21. Fusobacterium nucleatum: an emerging bug in colorectal tumorigenesis.
    Bashir A; Miskeen AY; Bhat A; Fazili KM; Ganai BA
    Eur J Cancer Prev; 2015 Sep; 24(5):373-85. PubMed ID: 25569450
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of Antibody Responses to Fusobacterium nucleatum and Streptococcus gallolyticus Proteins with Colorectal Adenoma and Colorectal Cancer.
    Genua F; Butt J; Waterboer T; Hughes DJ
    Dig Dis Sci; 2023 Aug; 68(8):3300-3311. PubMed ID: 37338617
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fusobacterium Nucleatum Is a Risk Factor for Metastatic Colorectal Cancer.
    Chen WD; Zhang X; Zhang YP; Yue CB; Wang YL; Pan HW; Zhang YL; Liu H; Zhang Y
    Curr Med Sci; 2022 Jun; 42(3):538-547. PubMed ID: 35678912
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of Fusobaterium nucleatum in feces and colorectal mucosa as a risk factor for colorectal cancer: a systematic review and meta-analysis.
    Janati AI; Karp I; Laprise C; Sabri H; Emami E
    Syst Rev; 2020 Dec; 9(1):276. PubMed ID: 33272322
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between
    Proença MA; Biselli JM; Succi M; Severino FE; Berardinelli GN; Caetano A; Reis RM; Hughes DJ; Silva AE
    World J Gastroenterol; 2018 Dec; 24(47):5351-5365. PubMed ID: 30598580
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metformin elicits antitumour effect by modulation of the gut microbiota and rescues Fusobacterium nucleatum-induced colorectal tumourigenesis.
    Huang X; Hong X; Wang J; Sun T; Yu T; Yu Y; Fang J; Xiong H
    EBioMedicine; 2020 Nov; 61():103037. PubMed ID: 33039709
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of Fusobacterium nucleatum in stool and colonic tissues from Norwegian colorectal cancer patients.
    Tunsjø HS; Gundersen G; Rangnes F; Noone JC; Endres A; Bemanian V
    Eur J Clin Microbiol Infect Dis; 2019 Jul; 38(7):1367-1376. PubMed ID: 31025134
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diets That Promote Colon Inflammation Associate With Risk of Colorectal Carcinomas That Contain Fusobacterium nucleatum.
    Liu L; Tabung FK; Zhang X; Nowak JA; Qian ZR; Hamada T; Nevo D; Bullman S; Mima K; Kosumi K; da Silva A; Song M; Cao Y; Twombly TS; Shi Y; Liu H; Gu M; Koh H; Li W; Du C; Chen Y; Li C; Li W; Mehta RS; Wu K; Wang M; Kostic AD; Giannakis M; Garrett WS; Hutthenhower C; Chan AT; Fuchs CS; Nishihara R; Ogino S; Giovannucci EL
    Clin Gastroenterol Hepatol; 2018 Oct; 16(10):1622-1631.e3. PubMed ID: 29702299
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fusobacterium in colonic flora and molecular features of colorectal carcinoma.
    Tahara T; Yamamoto E; Suzuki H; Maruyama R; Chung W; Garriga J; Jelinek J; Yamano HO; Sugai T; An B; Shureiqi I; Toyota M; Kondo Y; Estécio MR; Issa JP
    Cancer Res; 2014 Mar; 74(5):1311-8. PubMed ID: 24385213
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fusobacterium nucleatum induces oxaliplatin resistance by inhibiting ferroptosis through E-cadherin/β-catenin/GPX4 axis in colorectal cancer.
    Li B; Wei Z; Wang Z; Xu F; Yang J; Lin B; Chen Y; Wenren H; Wu L; Guo X; Liu Y; Wei Y
    Free Radic Biol Med; 2024 Aug; 220():125-138. PubMed ID: 38657754
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic Performance of Intestinal
    Peng BJ; Cao CY; Li W; Zhou YJ; Zhang Y; Nie YQ; Cao YW; Li YY
    Chin Med J (Engl); 2018 Jun; 131(11):1349-1356. PubMed ID: 29786050
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of
    Sun CH; Li BB; Wang B; Zhao J; Zhang XY; Li TT; Li WB; Tang D; Qiu MJ; Wang XC; Zhu CM; Qian ZR
    Chronic Dis Transl Med; 2019 Sep; 5(3):178-187. PubMed ID: 31891129
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is a fusobacterium nucleatum infection in the colon a risk factor for colorectal cancer?: a systematic review and meta-analysis protocol.
    Idrissi Janati A; Karp I; Sabri H; Emami E
    Syst Rev; 2019 May; 8(1):114. PubMed ID: 31077259
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fap2 Mediates Fusobacterium nucleatum Colorectal Adenocarcinoma Enrichment by Binding to Tumor-Expressed Gal-GalNAc.
    Abed J; Emgård JE; Zamir G; Faroja M; Almogy G; Grenov A; Sol A; Naor R; Pikarsky E; Atlan KA; Mellul A; Chaushu S; Manson AL; Earl AM; Ou N; Brennan CA; Garrett WS; Bachrach G
    Cell Host Microbe; 2016 Aug; 20(2):215-25. PubMed ID: 27512904
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Involvement of
    He Z; Tian W; Wei Q; Xu J
    Front Immunol; 2022; 13():968649. PubMed ID: 36059542
    [No Abstract]   [Full Text] [Related]  

  • 36. FadA promotes DNA damage and progression of Fusobacterium nucleatum-induced colorectal cancer through up-regulation of chk2.
    Guo P; Tian Z; Kong X; Yang L; Shan X; Dong B; Ding X; Jing X; Jiang C; Jiang N; Yu Y
    J Exp Clin Cancer Res; 2020 Sep; 39(1):202. PubMed ID: 32993749
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Berberine may rescue Fusobacterium nucleatum-induced colorectal tumorigenesis by modulating the tumor microenvironment.
    Yu YN; Yu TC; Zhao HJ; Sun TT; Chen HM; Chen HY; An HF; Weng YR; Yu J; Li M; Qin WX; Ma X; Shen N; Hong J; Fang JY
    Oncotarget; 2015 Oct; 6(31):32013-26. PubMed ID: 26397137
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    Hong J; Guo F; Lu SY; Shen C; Ma D; Zhang X; Xie Y; Yan T; Yu T; Sun T; Qian Y; Zhong M; Chen J; Peng Y; Wang C; Zhou X; Liu J; Liu Q; Ma X; Chen YX; Chen H; Fang JY
    Gut; 2021 Nov; 70(11):2123-2137. PubMed ID: 33318144
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment.
    Kostic AD; Chun E; Robertson L; Glickman JN; Gallini CA; Michaud M; Clancy TE; Chung DC; Lochhead P; Hold GL; El-Omar EM; Brenner D; Fuchs CS; Meyerson M; Garrett WS
    Cell Host Microbe; 2013 Aug; 14(2):207-15. PubMed ID: 23954159
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fusobacterium and Escherichia: models of colorectal cancer driven by microbiota and the utility of microbiota in colorectal cancer screening.
    Leung A; Tsoi H; Yu J
    Expert Rev Gastroenterol Hepatol; 2015 May; 9(5):651-7. PubMed ID: 25582922
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.